Text Size

Preoperative Cataract Pupillary Dilation: Inpatient At The Ambulatory Surgery Center vs Outpatient Dilation Prior To Arrival At The Ambulatory Surgery Center

This study has been completed.
Sponsor:
Information provided by:
Northwest Kansas Surgery Center
ClinicalTrials.gov Identifier:
NCT01169688
First received: July 22, 2010
Last updated: NA
Last verified: December 2007
History: No changes posted
  Purpose

This study was done to compare efficacy, safety and efficiencies of various methods of pupil dilation prior to cataract surgery.


Condition Intervention
Pupil Dilation Prior to Cataract Surgery In-patient
Pupil Dilation Prior to Cataract Surgery Out-patient
 Other: Pupil dilation with phenylephrine 10% vs cyclopentolate 2%

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Official Title: Preoperative Cataract Pupillary Dilation: Inpatient vs Outpatient

Resource links provided by NLM:

MedlinePlus related topics: Cataract
U.S. FDA Resources

Further study details as provided by Northwest Kansas Surgery Center:

Enrollment: 50
Study Start Date: December 2007
Study Completion Date: April 2008
Primary Completion Date: April 2008 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Ability to self administer eye or have a helper for the task of administering eye drops.
  • Ability to follow and eye drop administration schedule.
  • No noted ocular abnormalities.
  • Bilateral cataract surgery anticipated.

Exclusion Criteria:

  • Inability to self administer eye drops or have assistance with eye drop administration.
  • Health problems that would contraindicate self administration of dilating eye drops such as poor cardiovascular or respiratory status.
  Contacts and Locations
No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: Ronald Holweger MD, Northwest Kansas Surgery Center
ClinicalTrials.gov Identifier: NCT01169688     History of Changes
Other Study ID Numbers: NWKSC_2007_01
Study First Received: July 22, 2010
Last Updated: July 22, 2010
Health Authority: United States: Institutional Review Board

Keywords provided by Northwest Kansas Surgery Center:
Cataract Surgery
Pupillary Dilation

Additional relevant MeSH terms:
Dilatation, Pathologic
Mydriasis
Cataract
Pathological Conditions, Anatomical
Pupil Disorders
Eye Diseases
Lens Diseases
Cyclopentolate
Phenylephrine
Oxymetazoline
Mydriatics
Autonomic Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Pharmacologic Actions
 Parasympatholytics
Muscarinic Antagonists
Cholinergic Antagonists
Cholinergic Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Adrenergic alpha-1 Receptor Agonists
Adrenergic alpha-Agonists
Adrenergic Agonists
Adrenergic Agents
Cardiotonic Agents
Cardiovascular Agents
Therapeutic Uses
Sympathomimetics
Vasoconstrictor Agents

ClinicalTrials.gov processed this record on May 23, 2013